Blog

Dr. Anthony Sabatelli of Dilworth IP will join Dr. Susan Froshauer CEO of CURE (Connecticut United for Research Experience) for the 2016 BIO Legislative Day Fly-In on April 12th and 13th in Washington D.C. This annual event gives biotechnology executives from across the country the opportunity to discuss the most important legislative issues currently facing their industry with Members of Congress. All who attend the Fly-in will be provided with an intense legislative briefing before visiting Capitol Hill for their scheduled congressional meetings. The agenda for this year’s event will include topics involving National Institutes of Health research funding, the U.S. patent system, and Medicare reimbursement. Dr. Sabatelli, who has been attending this annual event for the past several years, said “the Fly-In is a unique opportunity for those of us advocating for the Biotech Industry to educate our legislators about issues vital to the continued health of this very important industry.”

Dilworth IP is proud to have sponsored the 2016 Yale Business Biotechnology Series which took place from March 28th to the 31st at Yale’s Anlyan Center in New Haven, CT. This program was established to help educate students and non-business professionals with a background in life sciences about the technology-finance ecosystem of the Biotech industry. Every night the seminar started with a one-hour course by Constance McKee of Manzanita Pharmaceuticals, and was followed by case studies presented by invited speakers. Dilworth IP’s Dr. Jing Zhou attended all four sessions of the course, and said “I think it was a wonderful event. It has speakers from different healthcare industries to show examples of various career paths, and provides a platform for students, postdocs and local professionals to network and share experiences.”

Dr. Jonathan Schuchardt, partner at Dilworth IP, will be hosting a FREE webinar on Wednesday April 20th at 1:00 PM (EDT). This session, entitled Unexpected Results under Section 103 and the Federal Circuit will explore recent Federal Circuit cases focused on the quantity and quality of unexpected results that a patentee needs to prevail over in a patentability challenge. The webinar will also touch upon other secondary considerations of non-obviousness and consider the impact of the Supreme Court’s decision in KSR v. Teleflex, particularly in the electromechanical arts.

The following article originated from the CURE NewsAlert:

CURE testified March 8 at the State Capitol in Hartford re S.B. No. 313, An Act Concerning Biological Products, stating that the bill “is in the best interest of patients, the State’s thriving biotechnology and pharmaceutical industries, healthcare providers, pharmacists, and the public at large.”

Dilworth IP is proud to be a sponsor of a young Connecticut inventor at this year’s National Invention Convention and Entrepreneurship Exposition’s (NICEE). Through the Connecticut Invention Convention, this program will send 30 young inventors from Connecticut to the United States Patent and Trademark Office in Alexandria, VA to participate in the first-ever national competition for young inventors and entrepreneurs.

Dilworth IP will be sponsoring the 2016 Yale Healthcare Case Competition which will be presented by Jackson Laboratories and held Saturday February 27 in Evans Hall at the Yale School of Business

Dilworth IP Partners Dr. Anthony Sabatelli and Mr. Frederick Spaeth will be presenting a talk on Intellectual Property basics at the Quinnipiac University Center for Innovation and Entrepreneurship on Friday March 4th at 12:00 PM. The talk will be geared toward prospective inventors and entrepreneurs and will cover key events over the life of a patent, common concerns of the patent process and patentability in biotechnology. For more information on the event, please contact QUCIE@quinnipiac.edu.

Dilworth IP welcomes Dr. Jing Zhou, a Technology Specialist who will be supporting the biotech and medical device practice areas of the firm.

Dilworth IP is proud to announce that Michael Dilworth has received the 2016 Client Choice Award for Excellence in Client Service for Patents. He recently accepted the award at a gala dinner held in London to honor all of this year’s recipients. As Michael noted, “It is an honor to receive this award on behalf of the entire Dilworth IP team, without whom I’d never have this opportunity. I am proud of my team and the recognition from our clients’ of the outstanding professionalism and client service that we constantly strive for at Dilworth IP.”

Dr. Anthony Sabatelli, head of Dilworth IP’s Pharmaceutical and Biotech Patent Practice, will be hosting the second of this year’s Dilworth IP Webinar Seminars. This session, entitled At the Intersection of Patent and Regulatory Law – Navigating the Challenges for Pharmaceuticals, will address the special challenges pharmaceutical products present for companies and their multidisciplinary teams. These challenges exist because pharmaceuticals, unlike most other chemical products, sit at the intersection of patent and regulatory law. In this webinar, Dr. Sabatelli will provide a basic introduction to the applicable patent and regulatory laws, focusing on their interplay over the product life cycle of a pharmaceutical product, from its inception in the lab, through R&D, human clinical testing, marketing, and eventual generic competition. Concepts such as patent term extension (35 USC 156), and the regulatory and market exclusivity periods granted upon approval of a NDA (21 USC 355) will be discussed. An example of a timeline for a pharmaceutical product will be presented to illustrate the fascinating interplay of these concepts and their importance for those multidisciplinary teams needing to make high stakes business decisions.